Dog · Canis lupus familiaris · typical adult weight 2.00–80.00 kg
Ivabradine is dosed at 0.1–0.5 mg/kg PO q12h in dogs, per JVIM 2020; Veterinary Cardiology Literature. Ivabradine is used in dogs for Heart rate reduction / chronic heart failure. Routes documented in dogs: PO. A typical adult dog weighs 2.00–80.00 kg. ExoticRx lists 1 cited dose rule for Ivabradine in dogs, drawn from published veterinary references. Verify against current literature before clinical use.
US trade names: Corlanor
| Route | Dose | Frequency | Duration | Indication | Evidence | Source |
|---|---|---|---|---|---|---|
| PO | 0.1–0.5 mg/kg | q12h | Long-term; titrate based on resting heart rate | Heart rate reduction / chronic heart failure | Moderate | JVIM 2020; Veterinary Cardiology Literature |
Need the exact dose for your patient?
These ranges are per kg. Enter your dog's weight to get the precise dose and draw-up volume — unit and concentration math done for you.
Selectively inhibits the hyperpolarization-activated cyclic nucleotide-gated (HCN) channel (funny current, If) in the sinoatrial node, reducing heart rate without affecting contractility.
Bradycardia risk. Avoid in atrial fibrillation or severe hepatic impairment. Emerging veterinary interest for feline hypertrophic cardiomyopathy.
Species-specific contraindications and adverse-reaction reports for dogs may differ from canine / feline reference data — consult the primary citations listed with each rule.
Ivabradine dose range in dogs, with cited source references: PO 0.1–0.5 mg/kg q12h. Reference ranges from cited sources — verify against current literature before clinical use.
Documented routes for Ivabradine in dogs: PO.
Cited course lengths for Ivabradine in dogs include: Long-term; titrate based on resting heart rate. Duration depends on the indication — match it to the specific dose rule in the table above.
Ivabradine is indicated in dogs for: Heart rate reduction / chronic heart failure.
These are general warnings for Ivabradine across species; consult the dog dosing table above for species-specific guidance. Bradycardia risk. Avoid in atrial fibrillation or severe hepatic impairment. Emerging veterinary interest for feline hypertrophic cardiomyopathy.
Why a species-specific page? Ivabradine pharmacokinetics differ across species: dose ranges, intervals, and route preferences are not interchangeable. Cross-extrapolation from canine doses is unsafe in dogs — the rules above are the citations specific to this species, not generic recommendations.
Sourced from published veterinary references; awaiting credentialed clinical reviewer. See our editorial process. Reference only — not veterinary advice.